|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
29,950,000 |
Market
Cap: |
96.74(M) |
Last
Volume: |
42,300 |
Avg
Vol: |
42,182 |
52
Week Range: |
$2.85 - $5.02 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Computer Hardware |
Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 9.1 |
Insider 6 Months : 9.1 |
Insider 3/6 Months : 18.2 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Anixa Biosciences is a biotechnology company developing therapies and vaccines that are focused on unmet needs in oncology and infectious disease. Co.'s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer and the discovery and development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. Co.'s vaccine programs include the development of a vaccine against triple negative breast cancer as well other forms of breast cancer and a vaccine against ovarian cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
55,009 |
55,009 |
60,509 |
60,509 |
Total Buy Value |
$182,130 |
$182,130 |
$202,150 |
$202,150 |
Total People Bought |
3 |
3 |
4 |
4 |
Total Buy Transactions |
3 |
3 |
4 |
4 |
Total Shares Sold |
0 |
0 |
11,800 |
11,800 |
Total Sell Value |
$0 |
$0 |
$42,126 |
$42,126 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Johnson Bruce F |
Director |
|
2015-03-20 |
4 |
B |
$0.11 |
$19,849 |
D/D |
188,325 |
7,950,898 |
2.39 |
- |
|
Titterton Lewis H Jr |
Director |
|
2015-03-18 |
4 |
B |
$0.09 |
$9,922 |
D/D |
110,000 |
10,979,025 |
2.39 |
- |
|
Johnson Bruce F |
Director |
|
2015-03-18 |
4 |
B |
$0.09 |
$20,277 |
D/D |
215,258 |
7,762,573 |
2.39 |
- |
|
Titterton Lewis H Jr |
Director |
|
2015-03-13 |
4 |
B |
$0.72 |
$72,000 |
D/D |
100,000 |
10,869,025 |
2.39 |
- |
|
Kumar Amit |
Director |
|
2015-03-13 |
4 |
B |
$0.08 |
$9,040 |
D/D |
113,000 |
1,502,691 |
2.39 |
- |
|
Titterton Lewis H Jr |
Director |
|
2015-03-12 |
4 |
B |
$0.08 |
$25,513 |
D/D |
325,000 |
10,769,025 |
2.39 |
- |
|
Herms Henry P |
Vice President-Finance & CFO |
|
2014-10-22 |
4 |
OE |
$0.15 |
$10,150 |
D/D |
70,000 |
553,125 |
|
- |
|
Titterton Lewis H Jr |
Director |
|
2014-07-15 |
4 |
B |
$0.00 |
$0 |
D/D |
100,000 |
10,444,025 |
2.31 |
- |
|
Kumar Amit |
Director |
|
2014-07-15 |
4 |
B |
$0.00 |
$0 |
D/D |
100,000 |
1,389,691 |
2.31 |
- |
|
Stender Tisha |
Chief Operating Officer |
|
2014-07-15 |
4 |
B |
$0.00 |
$0 |
D/D |
800,000 |
800,000 |
2.66 |
- |
|
Herms Henry P |
VP-Finance & CFO |
|
2014-04-29 |
4 |
OE |
$0.15 |
$725 |
D/D |
5,000 |
483,125 |
|
- |
|
236 Records found
|
|
Page 10 of 10 |
|
|